Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary A major challenge with immunotherapies, including those for glioblastoma, is the limited number of tumor-specific targets for the immune system to focus on; other targets may be enriched on tumor cells, but they run the risk of on-target, off-tumor effects. Here, Maich et al.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Mo
Contact Mo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack